Dr. Bonyadlou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 San Pablo St
Fl 2
Los Angeles, CA 90033Phone+1 323-442-8541Fax+1 323-442-8755
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Nuclear Medicine, 2002 - 2004
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Surgery, 2000 - 2002
- American University of the Caribbean School of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2002 - 2026
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 19 citationsPredictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer.Laurie L. Brunette, Shahram Bonyadlou, Lingyun Ji, Susan Groshen, Dena Shuster
Clinical Nuclear Medicine. 2018-11-01 - 2 citationsST Segment Elevation ECG Changes During Pharmacologic Stress With Regadenoson.Salima Qamruddin, Henry W. Huang, Anil Mehra, Shahram Bonyadlou, Andrew J. Yoon
Clinical Nuclear Medicine. 2016-01-01 - 5 citationsPositron emission tomography/computerized tomography imaging of multiple focus of neurolymphomatosisJames Peterson, Billur Caliskan, Shahram Bonyadlou
Indian Journal of Nuclear Medicine. 2014-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: